In January 2023, the FDA denied the requests in three citizen petitions — from the Consumer Healthcare Products Association, the Council for Responsible Nutrition and the Natural Products Association — that the FDA issue a regulation that would allow cannabidiol (CBD) products to be marketed as dietary supplements. The FDA’s responses, again, reiterated its position that it do... Read More